[go: up one dir, main page]

GB2033745B - Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions - Google Patents

Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions

Info

Publication number
GB2033745B
GB2033745B GB7918493A GB7918493A GB2033745B GB 2033745 B GB2033745 B GB 2033745B GB 7918493 A GB7918493 A GB 7918493A GB 7918493 A GB7918493 A GB 7918493A GB 2033745 B GB2033745 B GB 2033745B
Authority
GB
United Kingdom
Prior art keywords
prophylaxis
derivatives
treatment
fatty acid
thromboembolic conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7918493A
Other versions
GB2033745A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB7918493A priority Critical patent/GB2033745B/en
Publication of GB2033745A publication Critical patent/GB2033745A/en
Application granted granted Critical
Publication of GB2033745B publication Critical patent/GB2033745B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB7918493A 1978-05-26 1979-05-25 Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions Expired GB2033745B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB7918493A GB2033745B (en) 1978-05-26 1979-05-25 Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357478 1978-05-26
GB7918493A GB2033745B (en) 1978-05-26 1979-05-25 Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions

Publications (2)

Publication Number Publication Date
GB2033745A GB2033745A (en) 1980-05-29
GB2033745B true GB2033745B (en) 1983-08-17

Family

ID=26256600

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7918493A Expired GB2033745B (en) 1978-05-26 1979-05-25 Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions

Country Status (1)

Country Link
GB (1) GB2033745B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7737178B2 (en) 2000-02-16 2010-06-15 The Brigham And Woman's Hospital, Inc. Aspirin-triggered lipid mediators
US7803557B2 (en) 2003-03-05 2010-09-28 The Brigham And Women's Hospital, Inc. Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors
US7902257B2 (en) 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
US8273792B2 (en) 2005-10-03 2012-09-25 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
US8481772B2 (en) 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US8636986B2 (en) 2005-11-18 2014-01-28 The Forsyth Institute Treatment and prevention of bone loss using resolvins
CN103957903A (en) * 2011-09-15 2014-07-30 翁特拉制药公司 Methods and compositions for treating, reversing, inhibiting or preventing resistance to antiplatelet therapy
US9492545B2 (en) 2012-05-07 2016-11-15 Omthera Pharmaceuticals Inc. Compositions of statins and omega-3 fatty acids

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3152174A1 (en) * 1980-06-27 1982-08-12 Nippon Oils & Fats Co Ltd THROMBOSIS-PROPHYLATIC AND CURING AGENT
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
JPS59172416A (en) * 1983-03-18 1984-09-29 Terumo Corp Fat transfusion solution
US4607052A (en) * 1983-04-15 1986-08-19 Roussel-Uclaf Triglycerides, dietetic and therapeutical applications and compositions containing them
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
US5006281A (en) * 1985-03-26 1991-04-09 Century Laboratories, Inc. Process for the production of a marine animal oil
US4792418A (en) * 1985-08-14 1988-12-20 Century Laboratories, Inc. Method of extraction and purification of polyunsaturated fatty acids from natural sources
GB2197199B (en) * 1986-11-13 1991-04-03 Efamed Medicament for treatment of pregnancy-induced hypertension.
US4764392A (en) * 1987-04-01 1988-08-16 Q.P. Corporation Margarine containing fish oil
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
US4843095A (en) * 1987-08-07 1989-06-27 Century Laboratories, Inc. Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis
US4916130A (en) * 1987-09-08 1990-04-10 Green Cross Corporation Platelet agglutination-inhibiting agent
DE3734147C2 (en) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotonic omega-3 fatty acid-containing fat emulsion and its use
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
GB2222080A (en) * 1988-08-15 1990-02-28 Efamol Holdings Nutritional compositions comprising polyunsaturated fatty acid salts
US4963385A (en) * 1989-06-02 1990-10-16 Nabisco Brands, Inc. Stabilized emulsions containing highly unsaturated oils
US5288619A (en) * 1989-12-18 1994-02-22 Kraft General Foods, Inc. Enzymatic method for preparing transesterified oils
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
AU2002365167A1 (en) 2001-12-18 2003-07-09 The Brigham And Women's Hospital Inhibition or prevention of infection by bacteria with epa, dha or analogs
US7582785B2 (en) 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
SE0202188D0 (en) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
EP2295529B2 (en) 2002-07-11 2022-05-18 Basf As Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
WO2004014835A2 (en) 2002-08-12 2004-02-19 Brigham And Women's Hospital Resolvins: biotemplates for therapeutic interventions
US6846942B2 (en) 2003-05-20 2005-01-25 David Rubin Method for preparing pure EPA and pure DHA
WO2007066232A2 (en) * 2005-10-07 2007-06-14 Ocean Nutrition Canada Ltd. Salts of fatty acids and methods of making and using thereof
KR102118478B1 (en) * 2009-03-09 2020-06-04 바스프 에이에스 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7737178B2 (en) 2000-02-16 2010-06-15 The Brigham And Woman's Hospital, Inc. Aspirin-triggered lipid mediators
US8349896B2 (en) 2000-02-16 2013-01-08 The Brigham And Womens's Hospital, Inc. Aspirin-triggered lipid mediators
US7902257B2 (en) 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
US8461201B2 (en) 2002-04-01 2013-06-11 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US8481772B2 (en) 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US8802874B2 (en) 2002-04-01 2014-08-12 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US7803557B2 (en) 2003-03-05 2010-09-28 The Brigham And Women's Hospital, Inc. Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors
US8273792B2 (en) 2005-10-03 2012-09-25 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
US9364454B2 (en) 2005-10-03 2016-06-14 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers
US8636986B2 (en) 2005-11-18 2014-01-28 The Forsyth Institute Treatment and prevention of bone loss using resolvins
CN103957903A (en) * 2011-09-15 2014-07-30 翁特拉制药公司 Methods and compositions for treating, reversing, inhibiting or preventing resistance to antiplatelet therapy
US9492545B2 (en) 2012-05-07 2016-11-15 Omthera Pharmaceuticals Inc. Compositions of statins and omega-3 fatty acids

Also Published As

Publication number Publication date
GB2033745A (en) 1980-05-29

Similar Documents

Publication Publication Date Title
GB2033745B (en) Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
IL55227A (en) Pharmaceutical compositions comprising(all-z)-5,8,11,14,17-eicosapentaenoic acid or its salts,esters or amides for the treatment and prophylaxis of thromboembolic conditions
JPS54132582A (en) Manufacture of 44pyridonee33carboxylic acid and*or its derivative
DE2962418D1 (en) Pharmaceutical composition comprising 3-oxo-2,3-dihydro-(1)-benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of cardiovascular disturbance
JPS55148428A (en) Method of selectively electrochemically etching article to be treated
NZ186596A (en) 4-pyridazone derivatives and method of inducing male sterility in plants
DE2960499D1 (en) Process for the preparation of bi- and/or polyuret-polyisocyanates; products obtained by this process and their use in the preparation of polyurethanes
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
JPS53124232A (en) Derivative of aminosalicylic acid with ultraviolettray absorptiom effect and method of its preparation use
IL58869A0 (en) Preparation of glyoxylic acids and derivatives thereof
DE2960275D1 (en) Process for the preparation of acyloxysilanes and possibly acyloxysiloxanes
GB2030294B (en) Composition for determination of human b-microglobulin process for its preparation and its use
DE2965361D1 (en) Process for the preparation of optically active alpha-amino acids and their derivatives
DE2962925D1 (en) Process for the preparation of pure potassium ribonate and pure ribonolactone
JPS54144329A (en) Bissanthranilic acid derivative*its manufacture and use
DE2961090D1 (en) Processing of foodstuffs and composition for the protection of microorganisms used in foodstuff-processing
EP0000633A3 (en) 2,5 -disubstituted-3-substituted methyl-penta-2,4-dienoic acid and derivatives, process for their preparation and their use in the preparation of alpha-substituted-thien-3-yl acetic acid and derivatives
PH15923A (en) Coconut product and method of preparation
DE2965248D1 (en) Process for the preparation of delta keto-acids and derivatives thereof
GB2025226B (en) Carriomycin compositions for treatment and prophylaxis of swine dysentary
ZA796451B (en) Improvements relating to method and means for treatment of surfaces
JPS5581858A (en) Mercaptoacil derivative of pyrrolinecarboxylic acid and tetrahydropyridinecarboxylic acid
JPS54109930A (en) Long chain fatty acid amides and hydrazides* their cyclopropano analogue* their manufacture and use
JPS52108936A (en) Hydroxamic acid derivative* prparati of therof and plant growth rgulation composition containing same
DE2961009D1 (en) Cleaning composition and its preparation and method of cleaning

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19990524